These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 38599496)
1. Positive rate for carbapenem-resistant Enterobacterales in hospital water environment: a single-centre study in South Korea. Jo JL; Lee JY; Kim JY; Lim YJ; Kim EO; Jung J; Kim SH J Hosp Infect; 2024 Jul; 149():203-205. PubMed ID: 38599496 [No Abstract] [Full Text] [Related]
2. Carbapenemase-producing Enterobacteriaceae in South Korea: a report from the National Laboratory Surveillance System. Yoon EJ; Yang JW; Kim JO; Lee H; Lee KJ; Jeong SH Future Microbiol; 2018 Jun; 13():771-783. PubMed ID: 29478336 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of Invasive Infections Due to Carbapenem-Resistant Enterobacteriaceae among Adult Patients in U.S. Hospitals. Lodise T; Ye MJ; Zhao Q Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559271 [TBL] [Abstract][Full Text] [Related]
4. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018. Perovic O; Ismail H; Quan V; Bamford C; Nana T; Chibabhai V; Bhola P; Ramjathan P; Swe Swe-Han K; Wadula J; Whitelaw A; Smith M; Mbelle N; Singh-Moodley A; Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1287-1294. PubMed ID: 32124106 [TBL] [Abstract][Full Text] [Related]
5. Carbapenemen-resistant Enterobacterales: An issue of global concern. Nastro M Rev Argent Microbiol; 2024; 56(2):113-114. PubMed ID: 38914453 [No Abstract] [Full Text] [Related]
6. Prevalence and Characteristics of Carbapenemase-Producing Enterobacteriaceae in Three Tertiary-Care Korean University Hospitals between 2017 and 2018. Kim SH; Kim GR; Jeong J; Kim S; Shin JH Jpn J Infect Dis; 2020 Nov; 73(6):431-436. PubMed ID: 32475870 [TBL] [Abstract][Full Text] [Related]
7. Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study. Teo JQ; Chang CW; Leck H; Tang CY; Lee SJ; Cai Y; Ong RT; Koh TH; Tan TT; Kwa AL Int J Antimicrob Agents; 2019 May; 53(5):657-662. PubMed ID: 30880229 [TBL] [Abstract][Full Text] [Related]
9. Meropenem-Vaborbactam Activity against Carbapenem-Resistant Castanheira M; Doyle TB; Kantro V; Mendes RE; Shortridge D Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712207 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for in-hospital acquisition of carbapenem-resistant Enterobacterales in patients with severe burns. Han SB; Jeon K; Kim M; Park J; Yoon J; Cho YS; Hur J; Chun W; Kym D J Hosp Infect; 2024 Jul; 149():165-171. PubMed ID: 38740304 [TBL] [Abstract][Full Text] [Related]
11. Evidence from a New York City hospital of rising incidence of genetically diverse carbapenem-resistant Enterobacter cloacae and dominance of ST171, 2007-14. Gomez-Simmonds A; Hu Y; Sullivan SB; Wang Z; Whittier S; Uhlemann AC J Antimicrob Chemother; 2016 Aug; 71(8):2351-3. PubMed ID: 27118776 [No Abstract] [Full Text] [Related]
12. Carbapenem-Resistant Enterobacteriaceae: An update narrative review from Saudi Arabia. Alotaibi F J Infect Public Health; 2019; 12(4):465-471. PubMed ID: 31060974 [TBL] [Abstract][Full Text] [Related]
13. Molecular surveillance of carbapenem-resistant Enterobacterales in two nearby tertiary hospitals to identify regional spread of high-risk clones in Germany, 2019-2020. Boutin S; Welker S; Gerigk M; Miethke T; Heeg K; Nurjadi D J Hosp Infect; 2024 Jul; 149():126-134. PubMed ID: 38723905 [TBL] [Abstract][Full Text] [Related]
14. Incidence of a subsequent carbapenem-resistant Enterobacteriaceae infection after previous colonisation or infection: a prospective cohort study. Tang SSL; Chee E; Teo JQ; Chlebicki MP; Kwa ALH Int J Antimicrob Agents; 2021 Jun; 57(6):106340. PubMed ID: 33857538 [TBL] [Abstract][Full Text] [Related]
15. Tracking the spread of carbapenem-resistant Enterobacteriaceae (CRE) through clinical cultures alone underestimates the spread of CRE even more than anticipated. Lee BY; Bartsch SM; Wong KF; Kim DS; Cao C; Mueller LE; Gussin GM; McKinnell JA; Miller LG; Huang SS Infect Control Hosp Epidemiol; 2019 Jun; 40(6):731-734. PubMed ID: 30919795 [No Abstract] [Full Text] [Related]
16. Factors associated with carriage of carbapenem-non-susceptible Enterobacteriaceaein North-Eastern France and outcomes of infected patients. Muggeo A; Guillard T; Barbe C; Thierry A; Bajolet O; Vernet-Garnier V; Limelette A; Brasme L; De Champs C; J Antimicrob Chemother; 2017 May; 72(5):1496-1501. PubMed ID: 28158526 [TBL] [Abstract][Full Text] [Related]
17. Rapid Increase in Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) and Emergence of Colistin Resistance Gene Li Y; Sun QL; Shen Y; Zhang Y; Yang JW; Shu LB; Zhou HW; Wang Y; Wang B; Zhang R; Wang S; Shen Z J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29386265 [TBL] [Abstract][Full Text] [Related]